Holen Sie sich die Stockscreener-App
85.31
0.96%
0.795
Schlusskurs vom Vortag:
$84.51
Offen:
$85.14
24-Stunden-Volumen:
689.36K
Relative Volume:
0.53
Marktkapitalisierung:
$11.54B
Einnahmen:
$2.94B
Nettoeinkommen (Verlust:
$537.87M
KGV:
21.68
EPS:
3.9341
Netto-Cashflow:
$579.02M
1W Leistung:
-2.04%
1M Leistung:
-3.14%
6M Leistung:
+45.25%
1J Leistung:
+22.45%
1-Tages-Spanne:
$84.83
$86.75
1-Wochen-Bereich:
$84.34
$88.51
52-Wochen-Spanne:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
85.28 | 11.43B | 2.94B | 537.87M | 579.02M | 3.9341 |
|
ABT
Abbott Laboratories
|
108.53 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.51 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.33 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.09 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.51 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Hochstufung | Needham | Hold → Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2025-11-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-11-07 | Hochstufung | Truist | Hold → Buy |
| 2025-10-28 | Fortgesetzt | Stifel | Hold |
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Assessing Globus Medical (GMED) Valuation After Hammer Pattern Signal And Upgraded Earnings Outlook - Sahm
Aug Analyst Calls: Can Globus Medical Inc beat the S P 500Weekly Trend Report & Trade Opportunity Analysis - baoquankhu1.vn
Globus Medical Q1 EPS Estimate Increased by Zacks Research - MarketBeat
How The Globus Medical (GMED) Investment Story Is Evolving After Q4 Results And Nevro Update - Yahoo Finance
Assessing Globus Medical (GMED) After Recent Share Price Weakness And Fair Value Signals - Yahoo Finance
Does Globus Medical's (GMED) Reaffirmed 2026 Outlook Reveal Its Next Capital Allocation Priorities? - Yahoo Finance
5 Medical Device Stocks to Consider as Short-Term Price Surge Looms - Bitget
Bears are Losing Control Over Globus Medical (GMED), Here's Why It's a 'Buy' Now - Finviz
Globus Medical, Inc. $GMED Shares Bought by Victory Capital Management Inc. - MarketBeat
Healthcare Sector Analysis: Natera, ResMed, Globus Medical Driving InnovationNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Globus Medical Inc (NYSE:GMED): A GARP Stock with Strong Growth and a Reasonable Price - ChartMill
3 Healthcare Stocks to Target This Week - Finviz
Fisher Asset Management LLC Sells 278,122 Shares of Globus Medical, Inc. $GMED - MarketBeat
Will Globus Medical Inc. stock continue upward momentumShare Buyback & Weekly Stock Performance Updates - Naître et grandir
Aug Breakouts: Will Globus Medical Inc benefit from government policyInsider Selling & Comprehensive Market Scan Insights - baoquankhu1.vn
CYH Agreed to Sell 4 Arkansas Hospitals for $112M to Reduce Debt - TradingView
Globus Medical Expands Musculoskeletal Reach With New Technologies And M&A Integration - Yahoo Finance
Assessing Globus Medical (GMED) Valuation After Recent Share Price Pullback And Mixed Fair Value Signals - Sahm
Elo Mutual Pension Insurance Co Has $1.30 Million Stake in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (GMED) Slips on Acquisition and Robotics Segment Challenges - Insider Monkey
Globus Medical (NYSE:GMED) Stock Rating Upgraded by Zacks Research - MarketBeat
Here's Why Globus Medical (GMED) is a Strong Momentum Stock - Yahoo Finance
Is This the Right Time to Add Globus Medical Stock to Your Portfolio? - Nasdaq
GW&K Investment Management LLC Sells 72,271 Shares of Globus Medical, Inc. $GMED - MarketBeat
Burgundy Asset Management Ltd. Has $212.05 Million Stake in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical: Is the Post-Deal Integration Machine Turning NuVasive and Nevro Into a Real Musculoskeletal Powerhouse? - Smartkarma
Globus Medical Reports Fourth-Quarter and Full-Year 2025 Results - MyChesCo
Globus Medical (GMED) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
Segall Bryant & Hamill LLC Buys 13,583 Shares of Globus Medical, Inc. $GMED - MarketBeat
Champlain Investment Partners LLC Acquires 365,418 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical, Inc. (GMED) Stock Analysis: A Healthcare Innovator with 14.75% Upside Potential - DirectorsTalk Interviews
Globus Medical, Inc. $GMED Shares Purchased by William Blair Investment Management LLC - MarketBeat
DNB Asset Management AS Buys 67,911 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Stock After NuVasive Deal: Breakout Setup or Value Trap for US Investors? - AD HOC NEWS
Globus Medical (GMED) Is Up 5.4% After Record 2025 Earnings and Raised EPS Outlook Has The Bull Case Changed? - Sahm
Globus Medical (NYSE:GMED) EVP Sells $1,890,000.00 in Stock - MarketBeat
Globus Medical Executive Sells 20,000 Shares - TradingView
Globus Medical Insider Sold Shares Worth $1,890,000, According to a Recent SEC Filing - marketscreener.com
Globus Medical (GMED) EVP executes options, sells 20,000 shares under 10b5-1 plan - Stock Titan
Globus Medical Record Q4 And Synergies Refocus Valuation And Growth Debate - Yahoo Finance
Globus Medical (NYSE:GMED) Updates FY 2026 Earnings Guidance - MarketBeat
Wells Fargo Raises Price Target for GMED to $104 | GMED Stock Ne - GuruFocus
Wells Fargo & Company Raises Globus Medical (NYSE:GMED) Price Target to $104.00 - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Q4 2025 Earnings Call Transcript - Insider Monkey
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED), Standard BioTools (LAB) and Addus Homecare (ADUS) - The Globe and Mail
Globus Medical (GMED) Net Margin Reset Tests Bullish Long Term Earnings Narratives - simplywall.st
Truist raises Globus Medical stock price target on synergy gains - Investing.com South Africa
Globus Medical Earnings Call Shows Profitable Growth - TipRanks
GMED (GMED) Form 144: 20,000-share cashless option sale reported - Stock Titan
Globus Medical: Strengthening U.S. Spine Momentum and Innovation-Driven Double-Digit Growth Supports Buy Rating and Upside Valuation - TipRanks
Enovis (ENOV) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance UK
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):